Restoration of miR-7 levels could have therapeutic potential, as miR-7 targets the mRNA of epidermal growth factor receptor (EGFR) and α-synuclein, which are overexpressed in brain tissue from GBM and PD patients, respectively [112,113,114]. Here, EGFR is linked to Parkinson disease.